The interest in the therapeutic targeting of FURIN in atherosclerosis is growing and was recently investigated via a FURIN inhibitor in ApoE−/− and Ldlr−/− mouse models (Yakala et al., 2019). This evidence concerns the gene LDLR and atherosclerosis.